Scott L Burrows
CIK 1853327 · Chief Financial Officer · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.23M
Companies
3
Total Filings
26
Lifetime Open-Market Net
-$4.98M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRE | Chief Financial Officer | 105,494 | $99.96 | $10.55M | -$4.68M | 12 | 2026-07-02 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Chief Financial Officer | — | $12.01 | — | $0 | 1 | 2023-09-05 |
| ARQT | Chief Financial Officer | 59,115 | $28.42 | $1.68M | -$298.6K | 9 | 2023-03-08 |
Recent Filings · Page 2 of 3
26 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-03 | SYRE | Sell (S) | −18,428 | -$299.6K | EDGAR |
| 2025-01-17 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2024-09-05 | SYRE | Sell (S) | −18,531 | -$522.1K | EDGAR |
| 2024-02-02 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2023-12-22 | SYRE | Grant (A) | +134,953 | $0 | EDGAR |
| 2023-11-29 | ARQT | Notice (144) | −37,277 | -$77.0K | EDGAR |
| 2023-09-05 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-08 | ARQT | Sell (S) | −291 | -$4.4K | EDGAR |
| 2023-03-06 | ARQT | Grant (A) | +21,000 | $0 | EDGAR |
| 2023-03-02 | ARQT | Sell (S) | −1,850 | -$29.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.